Hims & Hers vs Restream
Side-by-side comparison of AI visibility scores, market position, and capabilities
Consumer telehealth platform with Q3 2025 revenue of $599M (+49% YoY); 2.47M subscribers; 2025 guidance $2.3-2.4B; acquiring ZAVA for European expansion; GLP-1 weight loss, hair, and sexual health treatments shipped directly to subscribers.
About
Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for conditions that people historically avoided treating due to embarrassment, cost, or access barriers. The platform's core technology combines a direct-to-consumer digital health interface with an integrated pharmacy network, enabling patients to complete asynchronous or synchronous consultations with licensed clinicians and receive prescription treatments — including compounded medications — delivered directly to their homes.\n\nHims & Hers serves patients across sexual health, hair loss, mental health, dermatology, and weight management. The company's expansion into GLP-1 compounded weight loss medications has been a significant growth catalyst, capitalizing on surging consumer demand for semaglutide and tirzepatide alternatives during periods of branded drug shortages. With 2.47 million subscribers and a subscription-centric business model, the platform generates predictable recurring revenue from patients on ongoing treatment protocols. The company's 2025 acquisition of ZAVA expands its addressable market into European telehealth markets.\n\nHims & Hers reported Q3 revenue of $599 million, a 49% year-over-year increase, and issued full-year 2025 guidance of $2.3 to $2.4 billion — a scale that makes it one of the largest consumer telehealth companies in the world. The company's ability to compound subscriber growth with expanding treatment categories and international expansion through ZAVA provides multiple vectors for continued revenue acceleration. As healthcare consumerization intensifies and patients increasingly manage chronic conditions through digital-first platforms, Hims & Hers' brand recognition, integrated pharmacy infrastructure, and subscription model give it a durable position in consumer health.
Austin multi-streaming platform broadcasting live video to 30+ destinations including Twitch, YouTube, and Facebook Live simultaneously; trusted by creators, media companies, and businesses.
About
Restream is an Austin-based live streaming company that provides multi-stream broadcasting technology enabling content creators, businesses, and media companies to broadcast live video simultaneously to over 30 streaming destinations including Twitch, YouTube, Facebook Live, LinkedIn Live, and custom RTMP destinations from a single source. The platform eliminates the need to choose a single streaming platform by enabling simultaneous multi-destination broadcasting, maximizing audience reach across wherever viewers are watching. Restream also provides a browser-based live studio for creating professional broadcasts without dedicated streaming hardware, including overlays, lower-thirds, guest invitations, and screen sharing. The company serves a broad range of users from gaming streamers and podcasters to corporate communications teams running product launches and all-hands meetings. Founded in 2015 in Kyiv with operations in Austin, Restream has grown to serve millions of streamers globally. The company raised over $50M from investors including Bessemer Venture Partners and competes with StreamYard, OBS, and Wirecast in the live streaming software market.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.